Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Description

Member of Farmavita.Net offers generic EU CTD Dossier of  Losartan, tablets, 25/50/100 mg.

Registration is going-on in refrence member state of EU.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Angiotensin II [formed from angiotensin I in a reaction catalyzed by angiotensin converting enzyme (ACE, kininase II)], is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex. Losartan and its principal active metabolite block the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor found in many tissues, (e.g., vascular smooth muscle, adrenal gland). There is also an AT2 receptor found in many tissues but it is not known to be associated with cardiovascular homeostasis.

More details at http://www.rxlist.com/cgi/generic/losar.htm 

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 37

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I want to give process knowhow and NON GMO...
n/a
499 Views
OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE...
575 Views
 Company portfolio: Manufacturing over 100...
1005 Views
Objective: To enter into EU domain procuring...
783 Views
Objective: To enter into EU domain grabbing a...
640 Views
OUT-LICENSING DOSSIER OF ALIMEMAZINE TABLETS OF...
588 Views
Please contact me.  if you need...
1150 Views